Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

New method helps better understand pathological development of ALS

The neurodegenerative disease ALS causes motor neuron death and paralysis. However, long before the cells die, they lose contact with the muscles as their axons atrophy.

12 Dec 2018

Research findings could lead to new targets for cancer-fighting therapeutics

A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study.

11 Dec 2018

HPV type 16 or 18 associated with cervical cancer risk in young women

The human papilloma virus can cause cervical cancer. According to new guidelines in Sweden, women over thirty therefore undergo initial screening for the virus rather than a smear test.

10 Dec 2018

Cervical cancer risk is higher in women with positive HPV, but no cellular abnormalities

Researchers have uncovered an increased risk of cervical cancer in women whose cervical cells test positive for certain high-risk human papillomavirus types but do not show any signs of cellular abnormalities.

10 Dec 2018

Researchers examine why HIV-infected patients have higher rates of cancer

AIDS patients suffer higher rates of cancer because they have fewer T-cells in their bodies to fight disease. But new research examines why HIV-infected patients have higher rates of cancer--among the leading causes of death among that population--than the general population.

5 Dec 2018

Mailing at-home HPV tests may be viable approach for screening hard-to-reach women

Screening women for HPV, or human papillomavirus, is a promising way to help detect cervical cancer early, but many at-risk women go without screening for the virus and without Pap tests that look for abnormal cells on the cervix.

28 Nov 2018

Using smartphone confocal microscopes to stop cancer

Dongkyun "DK" Kang was in the shower a few years ago when inspiration struck, and he became interested in the idea of imaging human tissue in vivo, or on a living person, using a smartphone attached to a microscope.

20 Nov 2018

Study aims to find which outreach method is more effective at improving cancer screening rates

Phone calls are more effective reminders for patients to book cancer screening appointments than mailed letters but are also more costly, suggests a new study from St. Michael's Hospital.

13 Nov 2018

Mailing self-collection HPV kits has potential to boost cervical cancer screening

University of North Carolina Lineberger Comprehensive Cancer Center researchers have found that mailing self-collection kits to test for high-risk human papillomavirus infection has the potential to boost cervical cancer screening - especially for low-income women who are overdue for testing.

7 Nov 2018

Study reveals how cancer-causing HPVs evolved

Cancer-causing human papillomaviruses diverged from their most recent common ancestors approximately half a million years ago, roughly coinciding with the timing of the split between archaic Neanderthals and modern Homo sapiens, according to a study published November 1 in the open-access journal PLOS Pathogens by Zigui Chen of the Chinese University of Hong Kong, Robert Burk of the Albert Einstein College of Medicine, and colleagues.

2 Nov 2018

Minimally invasive surgery for cervical cancer may not be a good idea finds a pair of studies

New research shows that keyhole surgery or minimally invasive laparoscopic robotic surgery could be dangerous in the long run for women with cervical cancer. Unlike open surgeries, minimally invasive surgeries are being increasingly conducted and preferred because of their minimal tissue damage, minimal pain and risk as well as faster recovery.

1 Nov 2018

Tall people more likely to get cancers, finds study

A new study suggests that tall people are more likely to get cancers because they have more number of cells that can undergo dangerous mutations.

24 Oct 2018

New liquid biopsy test confirms remission in patients with HPV-associated oropharyngeal cancer

A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related oropharyngeal squamous cell carcinoma are free from cancer following radiation therapy.

23 Oct 2018

Novel blood test shows promise for monitoring HPV-linked head and neck cancer after treatment

A new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked head and neck cancer patients to ensure they remain cancer-free after treatment.

23 Oct 2018

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck, known as MSD outside the United States and Canada, today announced the first presentation of preliminary data from a Phase 1 clinical trial evaluating MK-1454, an investigational STING (stimulator of interferon genes) agonist, as monotherapy and in combination with KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in patients with advanced solid tumors or lymphomas.

22 Oct 2018

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck, known as MSD outside the United States and Canada, today announced the first presentation of results from an interim analysis of KEYNOTE-057, a Phase 2 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, for previously treated patients with high-risk non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ or CIS plus papillary disease (Cohort A).

22 Oct 2018

HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study

A new study reveals that Hispanic HIV-infected adults in the United States are at a higher risk of developing cancers caused by the human papillomavirus than Hispanics from the general population.

22 Oct 2018

Could we prevent Alzheimer's disease by treating herpes?

An exciting new paper suggests that over half of all cases of Alzheimer’s disease could be traced back to herpes simplex virus 1, which causes cold sores.

19 Oct 2018

Immunotherapy effective for individuals with inherited form of skin cancer

Individuals with an inherited form of skin cancer often have a poor prognosis. The type of immunotherapy that was awarded this year's Nobel Prize in Physiology or Medicine is, however, particularly effective in this patient group, research from Karolinska Institutet in Sweden shows. The study is published in the Journal of Medical Genetics.

8 Oct 2018

Scientists discover new molecular pathway that controls colorectal cancer development

Scientists from the Cancer Science Institute of Singapore at the National University of Singapore have discovered a new molecular pathway that controls colorectal cancer development, and their exciting findings open new therapeutic opportunities.

8 Oct 2018

Cervical Cancer News and Research

Further Reading

New method helps better understand pathological development of ALS

Research findings could lead to new targets for cancer-fighting therapeutics

HPV type 16 or 18 associated with cervical cancer risk in young women

Cervical cancer risk is higher in women with positive HPV, but no cellular abnormalities

Researchers examine why HIV-infected patients have higher rates of cancer

Mailing at-home HPV tests may be viable approach for screening hard-to-reach women

Using smartphone confocal microscopes to stop cancer

Study aims to find which outreach method is more effective at improving cancer screening rates

Mailing self-collection HPV kits has potential to boost cervical cancer screening

Study reveals how cancer-causing HPVs evolved

Minimally invasive surgery for cervical cancer may not be a good idea finds a pair of studies

Tall people more likely to get cancers, finds study

New liquid biopsy test confirms remission in patients with HPV-associated oropharyngeal cancer

Novel blood test shows promise for monitoring HPV-linked head and neck cancer after treatment

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study

Could we prevent Alzheimer's disease by treating herpes?

Immunotherapy effective for individuals with inherited form of skin cancer

Scientists discover new molecular pathway that controls colorectal cancer development

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News